New implant targets prostate cancer from the inside
Disease control
Recruiting now
This early-stage study tests a small implant called Enolen that delivers the drug enzalutamide directly into the prostate. The goal is to see if it is safe and how much drug reaches the tumor. About 56 men with prostate cancer who are already scheduled for prostate removal surger…
Phase: PHASE1 • Sponsor: Alessa Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC